In addition, Jacquelot et al. documented that PD-L1 expression on peripheral blood T cells is prognostic on OS and progression-free survival (PFS) in anti-CTLA-4 antibody-treated melanoma patients [41]. The gene discussed is CTLA4; the disease is melanoma.